The Addiction Grants Modernization Act requires the Secretary of Health and Human Services to create a single online portal where organizations can apply for multiple federal substance use disorder grants from different agencies. This centralized system would allow applicants to submit one basic application for various programs, with additional specific questions added only when necessary for individual grants. To support this change, the bill mandates the creation of a working group made up of government employees and community stakeholders to develop the application process and report on its implementation. The legislation also requires agencies to synchronize their funding announcements but explicitly prohibits any changes to existing grant funding levels or allowable activities.
This House resolution formally supports the goals of Red Ribbon Week, an annual campaign held from October 23 through October 31, 2026, aimed at promoting drug-free communities and preventing substance abuse. The bill highlights the severity of the current drug crisis by citing statistics on overdose deaths involving fentanyl, methamphetamine, and cocaine, as well as the efforts of the Drug Enforcement Administration to combat illicit trafficking. It encourages the public to participate in awareness activities, such as wearing red ribbons and lighting up landmarks, while also urging individuals to choose healthy, drug-free lifestyles.
The Recovery First Housing Act requires organizations that receive federal funds for emergency shelter, transitional housing, or permanent housing to offer substance use disorder treatment to every adult admitted to their programs. This mandate applies to project sponsors operating under the McKinney-Vento Homeless Assistance Act and includes various levels of care, such as medically supervised withdrawal management, residential treatment, and outpatient services. The bill defines step-down treatment as a structured process for transitioning individuals from intensive care to community-based services. An exception is included for unaccompanied minors, who are not subject to this specific treatment requirement.
This Senate resolution supports designating October 2026 as "Substance Use & Misuse Prevention Month" to increase public awareness of drug and alcohol issues in the United States. The bill cites statistics from 2025 regarding binge drinking, illicit drug use, and the number of individuals with substance use disorders or currently in recovery. It expresses support for effective prevention programs and initiatives aimed at reducing the impact of the drug addiction and overdose epidemic.
The Emergency Responders Mental Health Training Act directs the Secretary of Health and Human Services to create a pilot fellowship program that funds postbaccalaureate training for mental health and substance use disorder professionals. This initiative aims to increase the number of culturally competent practitioners who understand the unique stressors, duties, and confidentiality requirements faced by emergency response providers such as police, firefighters, and EMTs. The bill authorizes $10 million in annual appropriations for fiscal years 2028 through 2033 to support these fellowships across fields including psychiatry, nursing, social work, and psychology. Additionally, the Secretary must submit reports to Congress two and five years after the program's establishment to evaluate its efficiency, impact on patient outcomes, and overall effectiveness.
This House resolution formally recognizes suicide as a serious public health problem in the United States and expresses support for designating September 2026 as National Suicide Prevention Month and September 10, 2026, as World Suicide Prevention Day. The bill cites data from the CDC, SAMHSA, and the VA to highlight that suicide is a leading cause of death among young people, veterans, and during the postpartum period, while also noting the significant economic costs associated with it. It declares suicide prevention a national priority and emphasizes that mental health is as important as physical health. The resolution supports the development of strategies to improve access to quality mental health, substance abuse, and suicide prevention services for all communities.
The End Gas Station Heroin Act adds two specific kratom compounds, 7-hydroxymitragynine and mitragynine pseudoindoxyl, to the federal list of Schedule I controlled substances. However, it includes an exemption for these compounds when they occur naturally in finished kratom products that meet strict concentration limits, while explicitly excluding synthetically produced or chemically concentrated versions from this protection. The bill also creates a new enforcement mechanism that treats any emerging synthetic opioid with greater potency than morphine as a Schedule I controlled substance if it is manufactured or distributed for commercial sale. This provision targets the production and distribution of these substances but explicitly prohibits criminal or civil penalties for simple possession or personal use by consumers.
The MORE Savings Act aims to reduce financial barriers for individuals seeking treatment for opioid use disorders by eliminating out-of-pocket costs for specific services. For Medicare beneficiaries, it establishes a five-year pilot program in 15 selected states that removes coinsurance, copayments, and deductibles for prescription drugs, behavioral health care, and community recovery support. Additionally, the bill mandates that private group health plans and individual insurance policies cover these same opioid treatments without cost-sharing requirements starting in 2027. Finally, it increases the federal funding match to 90 percent for states providing medication-assisted treatment through Medicaid and allows states to include recovery support services in this coverage.
This House resolution formally recognizes Overdose Awareness Day in the United States and calls for strengthened efforts to combat the opioid crisis. It directs the House of Representatives to pursue bipartisan legislation aimed at reducing the stigma associated with substance use disorders and drug overdoses. Additionally, the bill commits lawmakers to work with state and local governments, businesses, and health care providers to build a comprehensive system that supports prevention, treatment, harm reduction, and recovery for individuals affected by opioid use disorder.
Pennsylvania House Bill 2749 amends the state's Controlled Substance, Drug, Device and Cosmetic Act to expand legal protections for individuals and entities involved in responding to opioid overdoses. The bill grants immunity from criminal prosecution, civil liability, and professional disciplinary action to licensed health care professionals who prescribe or dispense opioid antagonists, including naloxone, as long as they act in good faith. It also extends similar protections to first responders, law enforcement, and private citizens who administer these medications to people they believe are suffering an overdose. Additionally, the legislation allows municipalities, local health departments, and community organizations to distribute expired opioid antagonists without facing legal liability, provided the medication is less than five years past its expiration date.
